User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 5 results.
    • Journal article
    Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study
    Mazzeo, Filomena[UCL] Duck, Lionel Joosens, Eric Dirix, Luc Focan, Christian Forget, Frédéric De Geest, Sabina Muermans, Katja VAN Lierde, Marie-Anne Macdonald, Karen Abraham, Ivo De Grève, Jacques (2011) Anticancer Research : international journal of cancer research and treatment — Vol. 31, no.4, p. 1407-1409 (2011)
    • Journal article
    Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group
    Vergote, Ignace Debruyne, Philippe Kridelka, Frédéric Berteloot, Patric Amant, Frédéric Honhon, Brigitte Lybaert, Willem Leunen, Karin Geldhof, Kurt Verhoeven, Didier Forget, Frédéric Vuylsteke, Peter D'Hondt, Lionel[UCL] Huizing, Manon Van Den Bulck, Heidi Laenen, Annouschka (2015) Gynecologic Oncology — Vol. 138, no. 2, p. 278-284 (2015)
    • Journal article
    Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
    Ryan, Charles J Rosenthal, Mark Ng, Siobhan Alumkal, Joshi Picus, Joel Gravis, Gwenaëlle Fizazi, Karim Forget, Frédéric Machiels, Jean-Pascal[UCL] Srinivas, Sandy Zhu, Min Tang, Rui Oliner, Kelly S Jiang, Yizhou Loh, Elwyn Dubey, Sarita Gerritsen, Winald R (2012) Clinical Cancer Research — Vol. 19, no. 1, p. 215-224 (2012)
    • Journal article
    Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
    Bidard, Francois-Clement Kaklamani, Virginia G Neven, Patrick Streich, Guillermo Montero, Alberto J Forget, Frédéric Mouret-Reynier, Marie-Ange Sohn, Joo Hyuk Taylor, Donatienne[UCL] Harnden, Kathleen K Khong, Hung Kocsis, Judit Dalenc, Florence Dillon, Patrick M Babu, Sunil Waters, Simon Deleu, Ines García Sáenz, José A Bria, Emilio Cazzaniga, Marina Lu, Janice Aftimos, Philippe Cortés, Javier Liu, Shubin Tonini, Giulia Laurent, Dirk Habboubi, Nassir Conlan, Maureen G Bardia, Aditya (2022) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — p. JCO2200338 (2022)
    • Journal article
    Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
    Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, Frédéric Holbrechts, Stéphane Delaunoit, Thierry Houbiers, Ghislain Kalantari, Hassan R Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Van Der Auwera, Jacques D'Hondt, Lionel[UCL] Pierre, Pascal Ghillemijn, Bjorn Covas, Angelique Paesmans, Marianne Ameye, Lieveke Awada, Ahmad Sclafani, Francesco Hendlisz, Alain (2021) Cancer medicine — Vol. 10, no. 13, p. 4366-4374 (2021)